Metformin up-regulated miR-107 expression and enhanced the inhibitory effect of miR-107 on gastric cancer growth
Authors:
Open Access
- 1 April 2020
- journal article
- research article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 9 (4) , 2941-2950
Abstract
Gastric cancer (GC) is one of the most common malignant neoplasms and is the third leading cause of cancer-related death around the world. Metformin has been well reported to have an inhibitory effect on the growth of various cancers by regulating the expression of microRNAs (miRNAs). However, the specific miRNA(s) regulated by metformin in GC have not been identified. In this study, real-time reverse transcription polymerase chain reaction (RT-PCR) analysis in vitro indicated that miR-107 expression was up-regulated in metformin-treated SGC-7901 cells compared with untreated SGC-7901 and MGC803 cells. Amplification of miR-107 expression further reduced cell proliferation in metformin-treated GC cells. A bioinformatics analysis showed that mitogen-activated protein kinase 8 (MAPK8) was the common target of metformin and miR-107. MAPK8 expression is associated with immune cell infiltration in GC as well as overall GC patient survival. Our study demonstrates that miR-107 enhances the anti-cancer effects of metformin in GC tissues, which offers a novel strategy for the treatment of GC.Keywords
This publication has 34 references indexed in Scilit:
- miR-107 regulates tumor progression by targeting NF1 in gastric cancerScientific Reports, 2016
- miR-27a-mediated antiproliferative effects of metformin on the breast cancer cell line MCF-7Oncology Reports, 2016
- The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast CancerInternational Journal of Molecular Sciences, 2016
- Screening differential circular RNA expression profiles reveals the regulatory role of circTCF25-miR-103a-3p/miR-107-CDK6 pathway in bladder carcinomaScientific Reports, 2016
- Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After GastrectomyAnnals of Surgery, 2016
- miR-106a-5p Inhibits the Proliferation and Migration of Astrocytoma Cells and Promotes Apoptosis by Targeting FASTKPLOS ONE, 2013
- The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation In Vitro and In VivoMolecular Cancer Therapeutics, 2012
- miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cellsMedical Oncology, 2011
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patientsBreast Cancer Research and Treatment, 2009
- MicroRNAs in CancerAnnual Review of Pathology: Mechanisms of Disease, 2009